Direct activation of TERT transcription by c-MYC - PubMed (original) (raw)
Direct activation of TERT transcription by c-MYC
K J Wu et al. Nat Genet. 1999 Feb.
Abstract
The MYC proto-oncogene encodes a ubiquitous transcription factor (c-MYC) involved in the control of cell proliferation and differentiation. Deregulated expression of c-MYC caused by gene amplification, retroviral insertion, or chromosomal translocation is associated with tumorigenesis. The function of c-MYC and its role in tumorigenesis are poorly understood because few c-MYC targets have been identified. Here we show that c-MYC has a direct role in induction of the activity of telomerase, the ribonucleoprotein complex expressed in proliferating and transformed cells, in which it preserves chromosome integrity by maintaining telomere length. c-MYC activates telomerase by inducing expression of its catalytic subunit, telomerase reverse transcriptase (TERT). Telomerase complex activity is dependent on TERT, a specialized type of reverse transcriptase. TERT and c-MYC are expressed in normal and transformed proliferating cells, downregulated in quiescent and terminally differentiated cells, and can both induce immortalization when constitutively expressed in transfected cells. Consistent with the recently reported association between MYC overexpression and induction of telomerase activity, we find here that the TERT promoter contains numerous c-MYC-binding sites that mediate TERT transcriptional activation. c-MYC-induced TERT expression is rapid and independent of cell proliferation and additional protein synthesis, consistent with direct transcriptional activation of TERT. Our results indicate that TERT is a target of c-MYC activity and identify a pathway linking cell proliferation and chromosome integrity in normal and neoplastic cells.
Similar articles
- Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation.
Greenberg RA, O'Hagan RC, Deng H, Xiao Q, Hann SR, Adams RR, Lichtsteiner S, Chin L, Morin GB, DePinho RA. Greenberg RA, et al. Oncogene. 1999 Feb 4;18(5):1219-26. doi: 10.1038/sj.onc.1202669. Oncogene. 1999. PMID: 10022128 - Regulation of human telomerase activity: repression by normal chromosome 3 abolishes nuclear telomerase reverse transcriptase transcripts but does not affect c-Myc activity.
Ducrest AL, Amacker M, Mathieu YD, Cuthbert AP, Trott DA, Newbold RF, Nabholz M, Lingner J. Ducrest AL, et al. Cancer Res. 2001 Oct 15;61(20):7594-602. Cancer Res. 2001. PMID: 11606399 - Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells.
Jagadeesh S, Kyo S, Banerjee PP. Jagadeesh S, et al. Cancer Res. 2006 Feb 15;66(4):2107-15. doi: 10.1158/0008-5472.CAN-05-2494. Cancer Res. 2006. PMID: 16489011 - Ets2 transcription factor, telomerase activity and breast cancer.
Dwyer JM, Liu JP. Dwyer JM, et al. Clin Exp Pharmacol Physiol. 2010 Jan;37(1):83-7. doi: 10.1111/j.1440-1681.2009.05236.x. Epub 2009 Jun 29. Clin Exp Pharmacol Physiol. 2010. PMID: 19566835 Review. - Feedback regulation of telomerase reverse transcriptase: new insight into the evolving field of telomerase in cancer.
Wu XQ, Huang C, He X, Tian YY, Zhou DX, He Y, Liu XH, Li J. Wu XQ, et al. Cell Signal. 2013 Dec;25(12):2462-8. doi: 10.1016/j.cellsig.2013.08.009. Epub 2013 Aug 29. Cell Signal. 2013. PMID: 23993966 Review.
Cited by
- Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy?
Behrooz AB, Syahir A. Behrooz AB, et al. Front Oncol. 2021 Apr 1;11:642719. doi: 10.3389/fonc.2021.642719. eCollection 2021. Front Oncol. 2021. PMID: 33869033 Free PMC article. Review. - Response of adult mouse uterus to early disruption of estrogen receptor-alpha signaling is influenced by Krüppel-like factor 9.
Simmons CD, Pabona JM, Zeng Z, Velarde MC, Gaddy D, Simmen FA, Simmen RC. Simmons CD, et al. J Endocrinol. 2010 May;205(2):147-57. doi: 10.1677/JOE-09-0474. Epub 2010 Feb 17. J Endocrinol. 2010. PMID: 20164373 Free PMC article. - Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT).
Kyo S, Takakura M, Taira T, Kanaya T, Itoh H, Yutsudo M, Ariga H, Inoue M. Kyo S, et al. Nucleic Acids Res. 2000 Feb 1;28(3):669-77. doi: 10.1093/nar/28.3.669. Nucleic Acids Res. 2000. PMID: 10637317 Free PMC article. - Subgrouping of Unfavorable Histology Neuroblastomas With Immunohistochemistry Toward Precision Prognosis and Therapy Stratification.
Ikegaki N, Shimada H; International Neuroblastoma Pathology Committee. Ikegaki N, et al. JCO Precis Oncol. 2019;3:PO.18.00312. doi: 10.1200/PO.18.00312. Epub 2019 May 17. JCO Precis Oncol. 2019. PMID: 31840131 Free PMC article. No abstract available. - Bmi1, stem cells, and senescence regulation.
Park IK, Morrison SJ, Clarke MF. Park IK, et al. J Clin Invest. 2004 Jan;113(2):175-9. doi: 10.1172/JCI20800. J Clin Invest. 2004. PMID: 14722607 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources